Skip to content
10-Q

Quarterly Report

ARDEA BIOSCIENCES, INC./DE

0001193125-12-215187

← back to feed
Filed
May 7, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Apr 27, 2012 36.86M sh
Capex Q1 2012 · Mar 31, 2012 $105K
Capex Q1 2012 · Mar 31, 2011 $122K
Operating Cash Flow Q1 2012 · Mar 31, 2012 −$40.7M
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$1.73M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $88.74M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $4.44M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $53.66M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $15.93M
Stockholders Equity Q1 2012 · Mar 31, 2012 $202.46M
Stockholders Equity Q1 2012 · Dec 31, 2011 $82.25M
Current Liabilities Q1 2012 · Mar 31, 2012 $23.09M
Current Liabilities Q1 2012 · Dec 31, 2011 $21.54M
Current Assets Q1 2012 · Mar 31, 2012 $221.98M
Current Assets Q1 2012 · Dec 31, 2011 $100.1M
Total Assets Q1 2012 · Mar 31, 2012 $225.97M
Total Assets Q1 2012 · Dec 31, 2011 $104.23M
Sga Expense Q1 2012 · Mar 31, 2012 $5.69M
Sga Expense Q1 2012 · Mar 31, 2011 $4.25M
Rd Expense Q1 2012 · Mar 31, 2012 $36.8M
Rd Expense Q1 2012 · Mar 31, 2011 $12.72M
Net Income Q1 2012 · Mar 31, 2012 −$40.92M
Net Income Q1 2012 · Mar 31, 2011 −$15.22M
Operating Income Q1 2012 · Mar 31, 2012 −$41.01M
Operating Income Q1 2012 · Mar 31, 2011 −$15.19M
Revenue Q1 2012 · Mar 31, 2012 $1.48M
Revenue Q1 2012 · Mar 31, 2011 $1.77M